Live Quote · NASDAQVRAXHealthcare· Biotechnology

Virax Biolabs Group Limited

$0.33▼ 12.89%($-0.05)
MKT CAP $446.40KNEXT EARNINGS Dec 2, 2026
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
80
Valuation
20
Profitability
100
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRAX research report →

Analyst Price Target
$1.00+201.3% vs. today

Range $1 – $1

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-96.70% · this period
$17.20$8.77$0.33Nov 20May 26Nov 20
52-Week Range0% of range
Low
$0.29
Current
$0.33
High
$21.75